Axsome Therapeutics (AXSM) Other Non-Current Assets (2015 - 2022)

Axsome Therapeutics has disclosed Other Non-Current Assets across 8 years of filings, most recently posting $507464.0 for Q2 2022.

• Other Non-Current Assets for Q2 2022 came in at $507464.0, up 59.89% year-over-year; the trailing twelve-month figure through Jun 2022 was $507464.0 (up 59.89% YoY), and the FY2021 annual result was $322910.0, up 1.74% from the prior year.
• Other Non-Current Assets came in at $507464.0 for Q2 2022 at Axsome Therapeutics, up from $322910.0 in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $507464.0 in Q2 2022 to a low of $101516.0 in Q1 2019.
• The 5-year median for Other Non-Current Assets is $168969.0 (2019), against an average of $226134.4.
• Across the five-year window, Other Non-Current Assets plunged 40.23% in 2018 and soared 126.9% in 2020, its largest moves.
• Axsome Therapeutics' Other Non-Current Assets stood at $112345.0 in 2018, then grew by 24.5% to $139875.0 in 2019, then jumped by 126.9% to $317375.0 in 2020, then increased by 1.74% to $322910.0 in 2021, then soared by 57.15% to $507464.0 in 2022.
• The last three Other Non-Current Assets figures came in at $507464.0 (Q2 2022), $322910.0 (Q1 2022), and $322910.0 (Q4 2021), per Business Quant data.